Imagine a patient comes into your office with active RA or lupus. You diagnose her and prescribe medications for her active disease—rash, arthritis, and so forth—but you do nothing to address possible long-term complications. You don’t prescribe calcium or vitamin D to prevent osteoporosis, you don’t get a bone density scan, and you don’t order labs to check risk factors for heart disease.
Search results for: scleroderma
Cellular Therapy of Autoimmune Disease
Is a novel treatment breakthrough on the horizon?
A Regulatory Leader in Rheumatology
Jeffrey Siegel, MD: A rare combination of clinical scientist and regulatory collaborator
Study Groups: Where Information and Networking Mix
ACR study groups provide an excellent forum for networking at the ACR/ARHP Annual Scientific Meeting and are among the most highly sought-after sessions each year. Although study groups are not eligible for CME credits, they provide an opportunity for the exchange of new ideas and in-depth presentations of information. These groups give attendees the opportunity to discuss cases and share experiences with colleagues who share a common interest in one disease, a group of related disorders, or a specialized field of study.
Rheum and Race: Where Are We?
It is time to examine the role of race in the care we provide
Dr. Wolfe & the National Data Bank for Rheumatic Diseases (NBD)
A private database becomes a national resource
Myositis Mysteries
Why isn’t my myositis patient getting better?
Disappearing Dollars
What’s happening to federal research funding in rheumatology?
What Causes Nephrogenic Systemic Fibrosis?
Imaging studies and kidney problems may trigger this gadolinium-induced fibrosing syndrome
From Punch Cards to Patient Reporting
James F. Fries, MD, harnessed computers to address big questions